BioVectra operates from three, FDA-inspected facilities in Prince Edward Island, Canada, with the capacity to produce commercial-scale active pharmaceutical ingredients. Our operations are currently expanding to a fourth plant in Nova Scotia, offering further capacity for fermentation and small-scale complex chemistry.  Our facilities are equipped to provide synthetic organic chemistry, natural extraction of bioactive compounds from both plant and animal-based biomass sources, PEGylation and conjugation chemistry, and fermentation of a variety of molecule types.